|
1
|
Lomas A, Leonardi-Bee J and Bath-Hextall
F: A systematic review of worldwide incidence of nonmelanoma skin
cancer. Br J Dermatol. 166:1069–1080. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stratigos A, Garbe C, Lebbe C, Malvehy J,
del Marmol V, Pehamberger H, Peris K, Becker JC, Zalaudek I, Saiag
P, et al: European Dermatology Forum (EDF); European Association of
Dermato-Oncology (EADO); European Organization for Research and
Treatment of Cancer (EORTC): Diagnosis and treatment of invasive
squamous cell carcinoma of the skin: European consensus-based
interdisciplinary guideline. Eur J Cancer. 51:1989–2007. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Levine DE, Karia PS and Schmults CD:
Outcomes of patients with multiple cutaneous squamous cells
carcinomas: A 10-year single institution cohort study. JAMA
Dermatol. 151:1220–1225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schmults CD, Karia PS, Carter JB, Han J
and Qureshi AA: Factors predictive of recurrence and death from
cutaneous squamous cell carcinoma: A 10-year, single-institution
cohort study. JAMA Dermatol. 149:541–547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karia PS, Han J and Schmults CD: Cutaneous
squamous cell carcinoma: Estimated incidence of disease, nodal
metastasis, and deaths from disease in the United States, 2012. J
Am Acad Dermatol. 68:957–966. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang L, Zhang Z, Yang J, McLaughlin SH
and Barford D: Atomic structure of the APC/C and its mechanism of
protein ubiquitination. Nature. 522:450–454. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Primorac I and Musacchio A: Panta rhei:
The APC/C at steady state. J Cell Biol. 201:177–189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bharadwaj R and Yu H: The spindle
checkpoint, aneuploidy, and cancer. Oncogene. 23:2016–2027. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gayyed MF, El-Maqsoud NM, Tawfiek ER, El
Gelany SA and Rahman MF: A comprehensive analysis of CDC20
overexpression in common malignant tumors from multiple organs: Its
correlation with tumor grade and stage. Tumour Biol. 37:749–762.
2016. View Article : Google Scholar
|
|
10
|
Kato T, Daigo Y, Aragaki M, Ishikawa K,
Sato M and Kaji M: Overexpression of CDC20 predicts poor prognosis
in primary non-small cell lung cancer patients. J Surg Oncol.
106:423–430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ding ZY, Wu HR, Zhang JM, Huang GR and Ji
DD: Expression characteristics of CDC20 in gastric cancer and its
correlation with poor prognosis. Int J Clin Exp Pathol. 7:722–727.
2014.PubMed/NCBI
|
|
12
|
Karra H, Repo H, Ahonen I, Löyttyniemi E,
Pitkänen R, Lintunen M, Kuopio T, Söderström M and Kronqvist P:
Cdc20 and securin overexpression predict short-term breast cancer
survival. Br J Cancer. 110:2905–2913. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu WJ, Hu KS, Wang DS, Zeng ZL, Zhang DS,
Chen DL, Bai L and Xu RH: CDC20 overexpression predicts a poor
prognosis for patients with colorectal cancer. J Transl Med.
11:1422013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Gao JZ, Du JL, Huang ZX and Wei LX:
Increased CDC20 expression is associated with development and
progression of hepatocellular carcinoma. Int J Oncol. 45:1547–1555.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yam CH, Fung TK and Poon RY: Cyclin A in
cell cycle control and cancer. Cell Mol Life Sci. 59:1317–1326.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rieder CL: Mitosis in vertebrates: The
G2/M and M/A transitions and their associated checkpoints.
Chromosome Res. 19:291–306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wolf F, Wandke C, Isenberg N and Geley S:
Dose-dependent effects of stable cyclin B1 on progression through
mitosis in human cells. EMBO J. 25:2802–2813. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hameetman L, Commandeur S, Bavinck JN,
Wisgerhof HC, de Gruijl FR, Willemze R, Mullenders L, Tensen CP and
Vrieling H: Molecular profiling of cutaneous squamous cell
carcinomas and actinic keratoses from organ transplant recipients.
BMC Cancer. 13:582013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lambert SR, Mladkova N, Gulati A, Hamoudi
R, Purdie K, Cerio R, Leigh I, Proby C and Harwood CA: Key
differences identified between actinic keratosis and cutaneous
squamous cell carcinoma by transcriptome profiling. Br J Cancer.
110:520–529. 2014. View Article : Google Scholar :
|
|
20
|
Hu G, Liang L, Liu Y, Liu J, Tan X, Xu M,
Peng L, Zhai S, Li Q, Chu Z, et al: TWEAK/Fn14 Interaction Confers
Aggressive Properties to Cutaneous Squamous Cell Carcinoma. J
Invest Dermatol. November 8–2018.Epub ahead of print.
|
|
21
|
Livak KJ and Schmittgen TD: Livak KJ and
Schmittgen TD: Analysis of relative gene expression data using
real-time quantitative PCR and the 2-ΔΔCT method. Methods.
25:402–408. 2001. View Article : Google Scholar
|
|
22
|
Rheinwald JG and Beckett MA: Tumorigenic
keratinocyte lines requiring anchorage and fibroblast support
cultured from human squamous cell carcinomas. Cancer Res.
41:1657–1663. 1981.PubMed/NCBI
|
|
23
|
Que SKT, Zwald FO and Schmults CD:
Cutaneous squamous cell carcinoma: Incidence, risk factors,
diagnosis, and staging. J Am Acad Dermatol. 78:237–247. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Izawa D and Pines J: How APC/C-Cdc20
changes its substrate specificity in mitosis. Nat Cell Biol.
13:223–233. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang L, Zhang J, Wan L, Zhou X, Wang Z and
Wei W: Targeting Cdc20 as a novel cancer therapeutic strategy.
Pharmacol Ther. 151:141–151. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Geley S, Kramer E, Gieffers C, Gannon J,
Peters JM and Hunt T: Anaphase-promoting
complex/cyclosome-dependent proteolysis of human cyclin A starts at
the beginning of mitosis and is not subject to the spindle assembly
checkpoint. J Cell Biol. 153:137–148. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shang G, Ma X and Lv G: Cell division
cycle 20 promotes cell proliferation and invasion and inhibits
apoptosis in osteosarcoma cells. Cell Cycle. 17:43–52. 2018.
View Article : Google Scholar :
|
|
28
|
Lim HJ, Dimova NV, Tan MK, Sigoillot FD,
King RW and Shi Y: The G2/M regulator histone demethylase PHF8 is
targeted for degradation by the anaphase-promoting complex
containing CDC20. Mol Cell Biol. 33:4166–4180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song L and Rape M: Regulated degradation
of spindle assembly factors by the anaphase-promoting complex. Mol
Cell. 38:369–382. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wan L, Tan M, Yang J, Inuzuka H, Dai X, Wu
T, Liu J, Shaik S, Chen G, Deng J, et al: APC(Cdc20) suppresses
apoptosis through targeting Bim for ubiquitination and destruction.
Dev Cell. 29:377–391. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Harley ME, Allan LA, Sanderson HS and
Clarke PR: Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its
Cdc20-dependent destruction during mitotic arrest. EMBO J.
29:2407–2420. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ku AT, Miao Q and Nguyen H: Monitoring
Wnt/β-Catenin Signaling in Skin. Methods Mol Biol. 1481:127–140.
2016. View Article : Google Scholar
|
|
33
|
Zimmerli D, Cecconi V, Valenta T, Hausmann
G, Cantù C, Restivo G, Hafner J, Basler K and van den Broek M: WNT
ligands control initiation and progression of human
papillomavirus-driven squamous cell carcinoma. Oncogene.
37:3753–3762. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Blomberg M, He SY, Harwood C, Arron ST,
Demehri S and Green A: Research gaps in the management and
prevention of cutaneous squamous cell carcinoma in organ transplant
recipients. Br J Dermatol. 177:1225–1233. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Que SKT, Zwald FO and Schmults CD:
Cutaneous squamous cell carcinoma: Management of advanced and
high-stage tumors. J Am Acad Dermatol. 78:249–261. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang ML, Tao Y, Zhou WQ, Ma PC, Cao YP,
He CD, Wei J and Li LJ: All-trans retinoic acid induces cell-cycle
arrest in human cutaneous squamous carcinoma cells by inhibiting
the mitogen-activated protein kinase-activated protein 1 pathway.
Clin Exp Dermatol. 39:354–360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Riahi RR, Bush AE and Cohen PR: Topical
Retinoids: Therapeutic Mechanisms in the Treatment of Photodamaged
Skin. Am J Clin Dermatol. 17:265–276. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mukherjee A, Bhattacharyya J, Sagar MV and
Chaudhuri A: Liposomally encapsulated CDC20 siRNA inhibits both
solid melanoma tumor growth and spontaneous growth of intravenously
injected melanoma cells on mouse lung. Drug Deliv Transl Res.
3:224–234. 2013. View Article : Google Scholar : PubMed/NCBI
|
